ment under subparagraph (A) may be used to 
address key questions and gaps in evidence ad-
dressed by the national cannabis research agen-
da described in paragraphs (1) through (5) of 
section 409K. 
‘‘(2) RESEARCH
RESULTS.—The Director of 
NIH shall promptly disseminate research results 
under this subsection to relevant governmental, aca-
demic, and research entities. 
‘‘(c) DEFINITIONS.—In this section: 
‘‘(1) CANNABIS.—The term ‘cannabis’ has the 
meaning given the term ‘marihuana’ in section 102 
of the Controlled Substances Act. 
‘‘(2) INSTITUTION OF HIGHER EDUCATION.— 
The term ‘institution of higher education’ has the 
meaning given the term in section 101(a) of the 
Higher Education Act of 1965.’’. 
(b) REGISTRATION REQUIREMENTS.—Section 303(f) 
of the Controlled Substances Act (21 U.S.C. 823(f)) is 
amended by adding after the period at the end the fol-
lowing: ‘‘The Attorney General shall register under this 
part practitioners at Centers of Excellence in Cannabis 
Research designated under section 409L of the Public 
Health Service Act to conduct research with marihuana. 
No separate registration shall be required for each indi-
VerDate Sep 11 2014 
23:16 Sep 13, 2019
Jkt 089200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H4322.IH
H4322
kjohnson on DSK79L0C42 with BILLS
vidual employed by a Center of Excellence in Cannabis Re-
search who is conducting research described in subsection 
(a)(1) of that section and in accordance with applicable 
State and local laws, nor shall separate registrations be 
required for distinct research activities, including research 
activities related to distinct constituent compounds of 
marihuana or amended protocols. The registration shall 
expire on the date on which the entity is no longer des-
ignated as such a Center of Excellence in Cannabis Re-
search under that section. A Center of Excellence in Can-
nabis Research registered under this part may cultivate 
marihuana, including any constituent component of mari-
huana, to conduct research under this part if the Attorney 
General has determined that the research to be conducted 
is for legitimate scientific research and is consistent with 
effective controls against diversion. A Center of Excellence 
in Cannabis Research may contract with such additional 
manufacturers of marihuana registered under this section 
to meet the needs of the Center of Excellence in Cannabis 
Research to the maximum extent permissible under inter-
national treaties to which the United States is a signatory 
and which govern marihuana. Before entering into such 
contract, the Center of Excellence in Cannabis Research 
shall submit to the Attorney General a request to enter 
into the contract that includes information to demonstrate 
VerDate Sep 11 2014 
23:16 Sep 13, 2019
Jkt 089200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H4322.IH
H4322
kjohnson on DSK79L0C42 with BILLS
the experience or capability of the contractor to conduct 
such cultivation and assurances that the contractor will 
comply with the provisions of this Act. Not later than 60 
days after the date on which the request is submitted, the 
request shall be deemed to be approved by the Attorney 
General, unless the Attorney General determines that the 
granting of such request is inconsistent with the public 
interest. A Center of Excellence in Cannabis Research reg-
istered under this section may purchase or acquire com-
mercially available marihuana for the purpose of research 
described in section 409L(a)(1) of the Public Health Serv-
ice Act in accordance with the law of the State in which 
the transaction occurs. No Federal funds may be used by 
the Center of Excellence in Cannabis Research for such 
purchase or acquisition.’’. 
Æ 
VerDate Sep 11 2014 
23:16 Sep 13, 2019
Jkt 089200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6301
E:\BILLS\H4322.IH
H4322
kjohnson on DSK79L0C42 with BILLS